KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

HCA Healthcare (HCA) Shares Outstanding (Weighted Average) (2016 - 2025)

HCA Healthcare (HCA) has disclosed Shares Outstanding (Weighted Average) for 7 consecutive years, with $323.3 million as the latest value for Q4 2021.

  • On a quarterly basis, Shares Outstanding (Weighted Average) fell 4.42% to $323.3 million in Q4 2021 year-over-year; TTM through Dec 2021 was $323.3 million, a 4.42% decrease, with the full-year FY2021 number at $323.3 million, down 4.42% from a year prior.
  • Shares Outstanding (Weighted Average) was $323.3 million for Q4 2021 at HCA Healthcare, down from $328.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $362.3 million in Q4 2017 to a low of $323.3 million in Q4 2021.
  • A 5-year average of $341.3 million and a median of $341.2 million in 2019 define the central range for Shares Outstanding (Weighted Average).
  • Biggest YoY gain for Shares Outstanding (Weighted Average) was 0.04% in 2021; the steepest drop was 4.42% in 2021.
  • HCA Healthcare's Shares Outstanding (Weighted Average) stood at $362.3 million in 2017, then dropped by 4.14% to $347.3 million in 2018, then decreased by 1.75% to $341.2 million in 2019, then dropped by 0.86% to $338.3 million in 2020, then dropped by 4.42% to $323.3 million in 2021.
  • Per Business Quant, the three most recent readings for HCA's Shares Outstanding (Weighted Average) are $323.3 million (Q4 2021), $328.0 million (Q3 2021), and $333.1 million (Q2 2021).